1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,086 | 0,093 | 10:25 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | SYNTHETICMR AB: SyntheticMR publishes Annual Report for 2025 | 1 | Cision News | ||
| 07.04. | Change of date for the Annual General Meeting in SyntheticMR AB (publ) | 1 | Cision News | ||
| SYNTHETICMR Aktie jetzt für 0€ handeln | |||||
| 12.02. | Spotlight Stock Market: Market Notice 19/26 - Last day of trading in SyntheticMR AB's BTA | 1 | Cision News | ||
| 11.02. | SYNTHETICMR AB: SyntheticMR's rights issue has been registered - conversion of BTA into shares | 2 | Cision News | ||
| 06.02. | SYNTHETICMR AB: Year-End report January - December 2025 | 1 | Cision News | ||
| 04.02. | SYNTHETICMR AB: SyntheticMR publishes the outcome of the rights issue | 1 | Cision News | ||
| 20.01. | Today the subscription period commences in SyntheticMR AB's rights issue | 2 | Cision News | ||
| 19.01. | SyntheticMR AB publishes information document regarding the rights issue | 1 | Cision News | ||
| 19.01. | SyntheticMR AB publishes financial guidance ahead of the forthcoming rights issue | 1 | Cision News | ||
| 16.01. | SYNTHETICMR AB: Regulatory Approval for ARIA Monitoring Strengthens SyntheticMR's Position with a Broader Neuroimaging Offering | 1 | Cision News | ||
| 15.01. | SyntheticMR AB announces intention to publish financial guidance ahead of upcoming rights issue | 1 | Cision News | ||
| 14.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.01.2026 | 502 | Xetra Newsboard | Das Instrument 9480 SE0015987946 SYNTHETICMR AB AK EQUITY wird cum Kapitalmassnahme gehandelt am 14.01.2026 und ex Kapitalmassnahme am 15.01.2026 The instrument 9480 SE0015987946 SYNTHETICMR AB AK EQUITY... ► Artikel lesen | |
| 09.01. | Spotlight Stock Market: Market Notice 5/26 - Information regarding the rights issue from SyntheticMR AB | 2 | Cision News | ||
| 09.01. | Report from the extraordinary general meeting in SyntheticMR AB (publ) | 2 | Cision News | ||
| 18.12.25 | Notice of extra general meeting in SyntheticMR AB (publ) | 1 | Cision News | ||
| 17.12.25 | SyntheticMR AB resolves on a fully secured rights issue of approximately SEK 32.8 million | 1 | Cision News | ||
| 28.11.25 | SyntheticMR AB Q3 Loss Climbs | 1 | RTTNews | ||
| 25.11.25 | SyntheticMR AB (publ) postpones the interim report for the third quarter of 2025 | 1 | Cision News | ||
| 22.11.25 | Marcel Warntjes resigns from the Board of Directors of SyntheticMR AB (publ) | 3 | Cision News | ||
| 29.10.25 | SYNTHETICMR AB: Nomination Committee appointed for the 2026 Annual General Meeting in SyntheticMR | 2 | Cision News |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NUGEN MEDICAL DEVICES | 0,013 | +21,82 % | NuGen Medical Devices Inc.: NuGen Files Patent for Ready-to-Fill COP/COC Needle-Free Injection Nozzle, Advancing Prefilled Nozzle Technology | Toronto, Ontario--(Newsfile Corp. - March 25, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"), a leader in needle-free drug delivery, today announced the filing of a new patent covering... ► Artikel lesen | |
| UNIDOC HEALTH | 0,069 | +9,15 % | UniDoc stellt Installation des H3 Health Cube in Italien fertig | - Der KI-gestützte Health Cube steht
ab sofort den Patienten im Dorf Guardia Perticara in der italienischen Region Basilikata zur Verfügung.
VANCOUVER, British Columbia... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,030 | +1,69 % | Mountain Valley MD Holdings Inc: Mountain Valley arranges offering, two debt settlements | ||
| LIGHT AI | 0,043 | -33,85 % | Light AI Inc. reports FY results | ||
| AROVELLA THERAPEUTICS | 0,051 | 0,00 % | AROVELLA THERAPEUTICS LIMITED: Notification of cessation of securities - ALA | ||
| PREVECEUTICAL MEDICAL | 0,005 | -35,71 % | PreveCeutical Medical Inc.: PreveCeutical Adopts Semi-Annual Financial Reporting | Vancouver, British Columbia--(Newsfile Corp. - April 1, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCID: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") announces that it has elected... ► Artikel lesen | |
| MEMPHASYS | 0,002 | 0,00 % | MEMPHASYS LIMITED: Investor Presentation - April 2026 | ||
| HERAMED | 0,025 | -7,41 % | HERAMED LIMITED: Notification regarding unquoted securities - HMD | ||
| THERMA BRIGHT | 0,044 | +12,82 % | Therma Bright Inc.: Therma Bright Signs New Strategic Customer, Horizon Health, Currently Selling over 35,000 Compression Products Annually | Therma Bright Builds on Revenue Progress with Initial 100-Unit Venowave Order; Signals Expansion into Cosmetic Wellness MarketToronto, Ontario--(Newsfile Corp. - March 31, 2026) - Therma Bright... ► Artikel lesen | |
| CARMAT | 0,099 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.03.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 24.03.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.03.2026.ISIN NameCA4013392051 GUARDIAN... ► Artikel lesen | |
| ARIKA RESOURCES | 0,012 | 0,00 % | ARIKA RESOURCES LIMITED: Becoming a substantial holder | ||
| PROCEPT BIOROBOTICS | 23,460 | 0,00 % | PROCEPT BioRobotics to Report First Quarter 2026 Financial Results on April 29, 2026 | ||
| SIEMENS HEALTHINEERS | 38,140 | +0,93 % | ANALYSE-FLASH: Goldman senkt Ziel für Siemens Healthineers - 'Neutral' | NEW YORK (dpa-AFX Broker) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 52 auf 45 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Vor der Berichtssaison... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,770 | +5,70 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler sichert Zugang zu entscheidender Augentumorbehandlung durch MDR-Zertifizierung für Ru-106 Augenapplikatoren | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Zulassungsgenehmigung
Eckert & Ziegler sichert Zugang zu entscheidender Augentumorbehandlung durch MDR-Zertifizierung für Ru-106... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,290 | +0,67 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen |
SYNTHETICMR AB gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,086 Euro und damit +38,84 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SYNTHETICMR AB finden Sie auf Wallstreet Online.